Meeting
2019 Genitourinary Cancers Symposium
Direct evidence of a clonal and tumor-directed T cell response to prostate cancer brachytherapy.
Authors
Scott Williams
Peter MacCallum Cancer Centre, Melbourne, Australia
Scott Williams , Simon Keam , Heloise Halse , Catherine Mitchell , Franco Caramia , David Byrne , Sue Haupt , Georgina Ryland , Phil Darcy , Shahneen Kaur Sandhu , Piers Blombery , Ygal Haupt , Paul J Neeson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 22)
DOI
10.1200/JCO.2019.37.7_suppl.22
Abstract #
22
Poster Bd #
B10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2022 ASCO Annual Meeting
Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance.
First Author: Hirotaka Miyashita
Poster
2018 ASCO Annual Meeting
Immune profiling in a randomized phase II trial of acalabrutinib and pembrolizumab (PA) versus pembrolizumab (P) for patients with metastatic urothelial cancer (mUC).
First Author: Tian Zhang
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Immunological impact of ramucirumab on tumor microenvironment in advanced gastric cancer.
First Author: Yosuke Togashi